Addex Therapeutics Ltd.
ADXN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574232
No open-market purchases or sales by Addex Therapeutics Ltd. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $274 in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Addex Therapeutics Ltd. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 5 | 10 | +5 |
| Shares | 1.28M | 6.12M | +4.84M (+377.0%) |
| Value | $1.48M | $1.21M | −$268.0K (−18.1%) |
New holders (6)
Institutions that held Addex Therapeutics Ltd. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 29,547 | $24.0K | 0.00% |
| FNY Investment Advisers, LLC | 22,500 | $17.0K | 0.01% |
| Millennium Management LLC | 19,957 | $16.0K | 0.00% |
| Citadel Advisors LLC | 12,803 | $10.0K | 0.00% |
| Two Sigma Securities, LLC | 12,076 | $10.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 124 | $0 | 0.00% |
Sold out (1)
Institutions that held Addex Therapeutics Ltd. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Old Mission Capital LLC | 31,134 | $36.0K |